Companies / Romania
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Antibiotice Privatisation Attracts Strong Interest
September 2006 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Highlighting the emerging importance of the Romanian pharmaceutical market, the Authority for State Asset Resolution has received 15 letters of interest for the privatisation of domestic drugmaker Antibiotice Iasi. The firm has selected evaluation company Darian to assess the letters and an announcement is expected in October